Hofseth Biocare
Hofseth Biocare ASA, commonly referred to as Hofseth Biocare, is a leading player in the biotechnology and health supplement industry, headquartered in Norway. Founded in 2009, the company has established itself as a pioneer in the development of high-quality marine ingredients, focusing on sustainable practices and innovative extraction methods. With operations primarily in Norway and a growing presence in international markets, Hofseth Biocare offers a range of unique products, including omega-3 fatty acids, collagen peptides, and other bioactive compounds derived from fish. Their commitment to sustainability and quality has positioned them as a trusted supplier in the health and wellness sector, earning recognition for their advanced research and development initiatives. As a result, Hofseth Biocare continues to make significant strides in promoting health through marine biotechnology.
DitchCarbon Score
How does Hofseth Biocare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hofseth Biocare's score of 46 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hofseth Biocare's reported carbon emissions
In 2023, Hofseth Biocare reported total carbon emissions of approximately 9,653,000 kg CO2e, with emissions distributed across various scopes: 1,850,000 kg CO2e from Scope 1, 46,000 kg CO2e from Scope 2, and 7,757,000 kg CO2e from Scope 3. This represents a significant increase from their 2022 emissions of about 13,403,000 kg CO2e, which included 2,104,000 kg CO2e from Scope 1, 4,761,000 kg CO2e from Scope 2, and 6,538,000 kg CO2e from Scope 3. In 2021, Hofseth Biocare's emissions were approximately 1,810,000 kg CO2e in Norway, all attributed to Scope 1, while in 2020, they reported total emissions of about 1,709,400 kg CO2e, with 1,619,000 kg CO2e from Scope 1 and 90,400 kg CO2e from Scope 2. Despite the increase in emissions, Hofseth Biocare has not publicly disclosed specific reduction targets or initiatives as part of their climate commitments. The company continues to monitor and report its emissions, aligning with industry standards for transparency and accountability in climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 1,619,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 90,400 | 00,000 | 00,000 | 00,000 |
| Scope 3 | - | - | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hofseth Biocare is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
